Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

antimicrobial peptide IB-367

Known as: IB-367 
 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Antimicrobial Cationic Peptides

Narrower (1)

iseganan

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
In vitro activity and in vivo animal model efficacy of IB-367 alone and in combination with imipenem and colistin against Gram-negative bacteria
The aim of our study was to evaluate the in vitro activity of IB-367 and its bactericidal effect for Pseudomonas aeruginosa and… Expand
  • table 1
  • table 2
  • table 4
Is this relevant?
2014
2014
In vitro activity of the protegrin IB-367 alone and in combination compared with conventional antifungal agents against dermatophytes.
The occurrence of resistance or side effects in patients receiving antifungal agents leads to failure in the treatment of mycosis… Expand
  • table 2
  • table 1
  • figure 2
  • figure 3
  • figure 1
Is this relevant?
2013
2013
IB-367 pre-treatment improves the in vivo efficacy of teicoplanin and daptomycin in an animal model of wounds infected with meticillin-resistant Staphylococcus aureus.
Antimicrobial peptides are known as immunomodulators and antibiotic enhancers. We report that administration of an antimicrobial… Expand
  • table 1
  • figure 1
  • figure 2
Is this relevant?
2010
2010
Antimicrobial and conformational studies of the active and inactive analogues of the protegrin-1 peptide.
The natural antimicrobial cationic peptide protegrin-1 displays a broad spectrum of antimicrobial activity and rapidly kills… Expand
Is this relevant?
2009
2009
Antimicrobial peptides (Temporin A and Iseganan IB-367): effect on the cysticerci of Taenia crassiceps.
Taenia solium infections continue being a health problem in undeveloped countries, and few effective control measures against… Expand
  • table 1
  • figure 2
  • figure 4
Is this relevant?
2007
2007
Pretreatment with the protegrin IB-367 affects Gram-positive biofilm and enhances the therapeutic efficacy of linezolid in animal models of central venous catheter infection.
BACKGROUND Biofilms play an important role in the pathogenesis of several chronic infections and nosocomial infections related to… Expand
Is this relevant?
2003
2003
Administration of protegrin peptide IB-367 to prevent endotoxin induced mortality in bile duct ligated rats.
BACKGROUND Postoperative morbidity in patients with obstructive jaundice remains high because of increased susceptibility to… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
Is this relevant?
2003
2003
Antiendotoxin activity of protegrin analog IB-367 alone or in combination with piperacillin in different animal models of septic shock
The therapeutic efficacy of protegrin peptide IB-367 was investigated in three rat models of septic shock: (i) rats injected… Expand
Is this relevant?
Highly Cited
2000
Highly Cited
2000
IB-367, a protegrin peptide with in vitro and in vivo activities against the microflora associated with oral mucositis.
Although the microflora associated with oral mucositis initiated by cytotoxic therapy is not well characterized, several studies… Expand
  • table 1
  • table 2
  • figure 1
  • figure 3
  • figure 2
Is this relevant?
1999
1999
Effect of local application of the antimicrobial peptide IB-367 on the incidence and severity of oral mucositis in hamsters.
OBJECTIVE The purpose of this animal study was to determine whether IB-367, an antimicrobial peptide, is able to ameliorate oral… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE